EDGAR MERCADO: Open Payments
NPI 1194380253 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,870 in 67 payments from 18 companies in 2025. Trend: 2023 $556 · 2024 $983 · 2025 $1,870
Food & beverage: $1,870
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 10 | $465 |
| Lilly USA, LLC | 10 | $289 |
| Corcept Therapeutics | 11 | $217 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $154 |
| Novo Nordisk Inc | 5 | $151 |
| ABBVIE INC. | 4 | $100 |
| Novartis Pharmaceuticals Corporation | 2 | $68 |
| Exact Sciences Corporation | 2 | $56 |
| Amgen Inc. | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $45 |
Products named: RECORLEV, MOUNJARO, Korlym, Kerendia, Wegovy, LEQVIO, Cologuard Collection Kit, QULIPTA.
Industry payments across CA — which companies pay providers there.
